Comparing Two Whole-Body Skin Photography Systems Used to Check for Melanoma
Compares two skin imaging systems for melanoma checks, looking at patient and dermatologist views.
Plain-language title generated from the registry record
Registry title: A Comparative Usability Study of Two Total Body Skin Imaging Systems
Key facts
- Where
- Basel, SwitzerlandSee the site
Where in Switzerland
- University Hospital BaselBasel, SwitzerlandNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Basel, Switzerland
- Trial code
- NCT07740642
- Record updated
- 3 August 2026
- Original description
This study aims to generate evidence on patient and dermatologist perspectives regarding two total body photography systems. Patient and clinician preferences represent key factors in healthcare decision-making. The investigation will also provide data on the time efficiency of each system in a real-world setting.Read full original descriptionShow less
A Comparative Usability Study of Two Total Body Skin Imaging Systems: Vectra (3D Total Body Photography With Manual Dermoscopy) Versus Deviskan (Total Body Photography With Automated Non-Contact Dermoscopy)
This study aims to generate evidence on patient and dermatologist perspectives regarding two total body photography systems. Patient and clinician preferences represent key factors in healthcare decision-making. The investigation will also provide data on the time efficiency of each system in a real-world setting.
Inclusion: Age ≥ 18 years; Signed informed consent by the participant; Sufficient proficiency in German; At least one of the following risk criteria for melanoma:; Previous melanoma (including in situ); Suspected melanoma; ≥ 100 common naevi; ≥ 5 dysplastic naevi; dysplastic naevus syndrome; Known CDKN2A mutation; Strong family history for melanoma (≥ first- and/or second-degree relatives).
Exclusion: Inability to follow the procedures of the investigation, including inability to follow on-screen instructions or to read (e.g. due to visual impairment or cognitive impairment); Active skin conditions that may impact the performance of TBP systems or skin cancer screenings; Cardiac pacemaker; Lack of informed consent; Immobility. (Patients must be able to stand without support for 30 minutes.); Vulnerable Subjects; Pregnant women (self reported, no pregnancy test planned); Height below 150 cm or above 195 cm; Severe Claustrophobia.